SIRT5 desuccinylates SHMT2 at K280, and SIRT3 deacetylates SHMT2 at K95, and both of these modifications activate SHMT2 enzyme activity, subsequently driving the degradation of serine to induce CRC carcinogenesis [122, 123]. This evidence concerns the gene SHMT2 and colorectal carcinoma.